There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares ...
Revenue: AU$6.14m (up 15% from FY 2024). Net loss: AU$6.11m (loss widened by 3.3% from FY 2024). AU$0.023 loss per share. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% ...
Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd is set to showcase its innovative medical devices at the Coffee Microcaps Morning Meeting with CEO Jeremy Steele leading the ...
Control Bionics (ASX:CBL) has officially launched its NeuroNode Only sales model in the US following recent issuance of US Medicare reimbursement code E2513 under the Healthcare Common Procedure ...
Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Limited has announced the issue of 500,000 new placement fee options as part of a transaction previously communicated in an ...
Commercialisation of its new NeuroStrip wearable tech progressing across sports science, stroke rehab and diagnostics, with trials underway in the US, Japan and Australia. NeuroBounce, its athlete ...
Control Bionics is on track for record revenue in FY25 driven by strong performance in the US and growth in Australia. Commercialisation of its new NeuroStrip wearable tech progressing across sports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results